• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,940.76 -42.42
( -0.06%)
Global Indices
Nasdaq
49,934.70 -958.41
(-1.88%)
Dow Jones
7,287.94 -119.71
(-1.62%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,254.58 27.25
(0.27%)
Forex
USD-INR
95.41 -0.12
(-0.12%)
EUR-INR
110.18 0.04
(0.03%)
GBP-INR
127.60 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

IRB InvIT Fund
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
540526
INE183W23014
105.4574955
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IRBINVIT
6.78
4778.12
EPS(TTM)
Face Value()
Div & Yield %
8.91
102
9.47
 

astec lifesciences ltd
Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
Feb 13,2026
Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.